TRH Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$7.26M Buy
80,905
+2,263
+3% +$229K 2.44% 19
2022
Q1
$8.72M Buy
78,642
+18,980
+32% +$2.01M 2.56% 14
2021
Q4
$6.17M Buy
59,662
+13,253
+29% +$1.53M 1.93% 27
2021
Q3
$5.82M Buy
46,409
+9,291
+25% +$1.2M 2.29% 17
2021
Q2
$4.61M Buy
37,118
+8,803
+31% +$1.11M 1.99% 19
2021
Q1
$3.35M Buy
28,315
+2,874
+11% +$337K 1.7% 21
2020
Q4
$2.98M Buy
25,441
+3,517
+16% +$387K 1.71% 22
2020
Q3
$2.28M Buy
21,924
+4,737
+28% +$476K 1.54% 21
2020
Q2
$1.57M Buy
+17,187
New +$1.65M 1.25% 27
2019
Q4
$1.17M Buy
+10,172
New +$1.12M 1.01% 31

Other funds holding MDT

TRH Financial's MDT Position: Q2 2022 in Review

TRH Financial increased its Medtronic (MDT) stake by 2.9% in Q2 2022, buying an estimated $229K and bringing the position to 80,905 shares worth $7.26M. The position accounts for 2.44% of the portfolio, ranked #19.

TRH Financial first reported a position in MDT in Q4 2019 and has held it in 10 quarters since. The position peaked at $8.72M in Q1 2022. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • TRH Financial held 80,905 shares of Medtronic worth $7.26M as of Q2 2022.
  • TRH Financial bought 2,263 Medtronic shares in Q2 2022, an estimated $229K.
  • Medtronic made up 2.44% of TRH Financial's portfolio in Q2 2022, its #19 holding.
  • TRH Financial first reported a position in Medtronic in Q4 2019 and has held it in 10 quarters since.
  • TRH Financial's Medtronic position peaked at $8.72M in Q1 2022.
  • 2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on TRH Financial's 13F filing for Q2 2022, filed 26 Jul 2022.